Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VYGR compared with BCYC: revenue, margins and what each company keeps, and the suppliers and customers both name
VYGR
Voyager Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
BCYC
Bicycle Therapeutics PLC
Change
Mkt cap
Revenue
Revenue
vs
Compare
VYGR
Voyager Therapeutics, Inc.
vs
BCYC
Bicycle Therapeutics PLC
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VYGR: latest quarter is a loss; flow not drawable. BCYC: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VYGR
2
NBIX
Neurocrine Biosciences
customer
NVS
Novartis Pharma
customer
Shared
0
No shared counterparties.
Only BCYC
2
—
Eckert & Ziegler Strahlen- und Medizintechnik
unlisted
supplier
—
Bayer Consumer Care
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VYGR, solid
BCYC, dashed
VYGR
Voyager Therapeutics, Inc.
Change
1.72
▼
−2.52%
· post 1.72
Mkt cap
$106.0M
Revenue
$3M
Q2 FY26
Revenue
$40M
FY25
BCYC
Bicycle Therapeutics PLC
Change
3.65
▼
−4.34%
· post 3.65
Closed
Oct 30 '26
Mkt cap
$256.5M
Revenue
$34M
Q3 FY26
Revenue
$73M
FY25
vs
Compare
Closed
Oct 30 '26
VYGR
Voyager Therapeutics, Inc.
vs
BCYC
Bicycle Therapeutics PLC
1.72
▼
−2.52%
post 1.72
Price
3.65
▼
−4.34%
post 3.65
$106.0M
Mkt cap
$256.5M
Q2 FY26
$3M
Revenue
$34M
Q3 FY26
FY25
$40M
Revenue
$73M
FY25
Change
Change
VYGR
1.72
▼
−2.52%
vs
BCYC
3.65
▼
−4.34%
Closed
Oct 30 '26